BRAIN Biotech
BNN.DE
#9049
Rank
NZ$0.14 B
Marketcap
$6.42
Share price
-1.70%
Change (1 day)
4.94%
Change (1 year)
Categories

Operating Margin for BRAIN Biotech (BNN.DE)

Operating Margin as of December 2024 (TTM): -15.17%

According to BRAIN Biotech's latest financial reports and stock price the company's current Operating Margin is -15.17%. At the end of 2023 the company had an Operating Margin of -11.98%.

Operating Margin history for BRAIN Biotech from 2015 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2023-11.98%5.27%
2022-11.38%16.38%
2021-9.78%-59.67%
2020-24.25%-11.75%
2019-27.48%-7.29%
2018-29.64%-21.62%
2017-37.82%-38.79%
2016-61.79%164.61%
2015-23.35%

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.